CN1043308C - Drug for exterior use for treating necrosis of femoral head - Google Patents
Drug for exterior use for treating necrosis of femoral head Download PDFInfo
- Publication number
- CN1043308C CN1043308C CN94114860A CN94114860A CN1043308C CN 1043308 C CN1043308 C CN 1043308C CN 94114860 A CN94114860 A CN 94114860A CN 94114860 A CN94114860 A CN 94114860A CN 1043308 C CN1043308 C CN 1043308C
- Authority
- CN
- China
- Prior art keywords
- gram
- radix
- grams
- medicine
- roots
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention discloses an externally applied agent for treating femoral head necrosis, which is prepared by mixing traditional Chinese medicinal materials in the following mixing proportions: 18 to 22g of realgar, 22 to 26g of rhizoma corydalis, 18 to 22g of notopterygium roots, 18 to 22g of catechu, 18 to 22g of radix dipsaci from Sichuan of China, 18 to 22g of bupleurum roots, 28 to 32g of astragalus roots, 28 to 32g of Chinese waxgourd seeds, 38 to 42g of crabs, 18 to 22g of Chinese angelica roots, 18 to 22g of Jiazhu, 18 to 22g of radix angenicae pubescentis, 18 to 22g of eupolyphaga ground beetles, 18 to 22g of morinda roots, 24 to 26g of magnets, 24 to 26g of toosendan fruits, 18 to 22g of pawpaws and 14 to 16g of leeches.
Description
The present invention relates to a kind of medicine for external use for the treatment of osteonecrosis of femoral head, belong to the Chinese medicine formulation art.
Hip joint is one of human body six big joints, is that human repeating motion is maximum, and the maximum joint of femoral head carrying in case necrose, will become a great problem in the medical domain, be called " new cancer ".General traditional medical science viewpoint thinks that bone necrosis, particularly femur head necrosis can not repair, and is irreversible.Therefore replace artificial joint, substitute the main treatment means that has just become this disease with prosthese.Artificial femoral head replacement's infectious-related complication is difficult to overcome, and occur to infect, loosening, joint stiffness, pain etc., can cause patient's lifelong disability.Research to the femur head necrosis paathogenic factor, be commonly considered as the necrosis that blood supply disorder causes in the femoral head, under this theoretical direction, treatment means is a purpose to improve the blood supply environment, has occurred Therapeutic Method such as vascular transplant, muscle flap vessel pedicle transplantation, bone lobe dislocation art, fetus cartilage dislocation art, interventional therapy in succession.Tcm therapy is based on blood circulation promoting and blood stasis dispelling, bone and muscle strengthening, nourishing the liver and kidney, and external treatment adopts the plaster external application.Above-mentioned therapy is to reparation, the treatment of necrotic femoral head, and the throughput fractional analysis does not still have final conclusion at aspects such as pathology, histologys.
Rationale is breakthrough to be discovered, the femur head necrosis paathogenic factor is not ischemic femoral head and blood supply disorder, but ultrastructure changes in the femoral head, internal stress of bone changes, the piezoelectric property of bone and electrokinetic property disorder, the electrical environment disequilibrium produces potential difference.This electrical environment destroys reason medicine source property, mechanicalness and chemical reason.Therapeutic Method then to improve the bio electricity environment, restores balance it.According to this theory, the inventor invents and has developed Huang Shi therapeutic apparatus for femoral head necrosis (China Patent No. CN92111451.6), is applied to the patient and has obtained excellent curative, and in order to improve curative effect, the inventor has developed the serial Chinese medicine that cooperates this instrument to use.
The object of the invention then provides the medicine for external use that a kind of Huang Shi of cooperation femoral head therapeutic instrument uses.
Medicine of the present invention is that the Chinese medicine with following weight proportion is the medicine for external use that raw material is made:
Realgar 18-22 gram Rhizoma Corydalis 22-26 gram Rhizoma Et Radix Notopterygii 18-22 gram
Catechu 18-22 gram Radix Dipsaci 18-22 gram Radix Bupleuri 18-22 gram
Radix Astragali 28-32 gram Semen Benincasae 28-32 gram Eriocheir sinensis 38-42 gram
Radix Angelicae Sinensis 18-22 gram Squama Manis 18-22 gram Radix Angelicae Pubescentis 18-22 gram
Eupolyphaga Seu Steleophaga 18-22 gram Radix Morindae Officinalis 18-22 gram Magnetitum 24-26 gram
Fructus Toosendan 24-26 gram Fructus Chaenomelis 18-22 gram Hirudo 14-16 gram
The preparation method of medicine for external use of the present invention is with the oven dry of above-mentioned raw materials medicine, is ground into smalls, packing, every bag 10 grams.
Medicine of the present invention and Huang Shi therapeutic apparatus for femoral head necrosis are used.During use medicine of the present invention is used gingerade furnishing pasty state, spread on (Chengfu, Tiaokou, femoral pulse point) on the acupuncture point with gauze, twice, three month on the one is a course of treatment.
Medicine of the present invention has the removing slough, rebuilds the effect of bone structure, biological girder system system, can be used for treating molten bone type femur head necrosis, and head subsides, distortion etc.
Medicine of the present invention in use uses through clinical 1027 examples, and 1782 hip joint treatments are analyzed, and total effective rate reaches 97.2%, and cure rate reaches 54.2%.Wherein:
1, improve hip joint function, take care of oneself, the hip joint activity is normal substantially, outer bend, interior receipts, bend hip, after stretch and reach normal physiological function scope person 842 examples, account for 41.5% of sum,
2, collapse of the femoral head, acetabular bone are destroyed, the joint stiffness patient removes sequestrum by treatment, the area of new bone structure occurs, and joint space improver 212 examples account for sum 11.9%.
3, pain relief, normal, the femoral head carrying improvement of terms of walking can be adhered to worker's 362 examples, accounts for sum 19.8%.
4, femur head necrosis is the sclerosis ischemic necrosis, the loose type patient of femoral head hypertrophy dwindles by the treatment femoral head, and improve the joint space, area of new bone girder person 126 examples occur, accounts for sum 7.3%.
5, femur head necrosis is molten bone destruction, a head distortion subluxation or a complete dislocation occur, also receives and resets through treating remaining femoral head, and sequestrum is removed, and newborn carrying bone trabecula improves the carrying environment, can the person's of taking care of oneself 137 examples, account for 7.9%.
6, femur head necrosis has been replaced artificial joint, pain and is liied in bed unbearably and can not walk, and through the treatment pain relief, can hold and turn walker 18 examples, accounts for sum 1.05%.
7, femur head necrosis underwent operative treatment, joint capsule destroyed hip joint structure biomechanics occurs and change, and nonresponder's 49 examples account for sum 2.8%.
Embodiment:
Composition of raw materials is as follows
Realgar 20 gram Rhizoma Corydalis 25 gram Rhizoma Et Radix Notopterygiis 20 grams
Catechu 20 gram Radix Dipsaci 20 gram Radix Bupleuri 20 grams
The Radix Astragali 30 gram Semen Benincasaes 30 gram Eriocheir sinensiss 40 grams
Radix Angelicae Sinensis 20 gram Squama Maniss 20 gram Radix Angelicae Pubescentiss 20 grams
Eupolyphaga Seu Steleophaga 20 gram Radix Morindae Officinaliss 20 gram Magnetitums 25 grams
Fructus Toosendan 25 gram Fructus Chaenomeliss 20 gram Hirudos 15 grams
With above-mentioned medical material oven dry, be ground into fine flour, packing, every bag 10 grams.
Claims (2)
1, a kind of medicine for the treatment of femur head necrosis is characterized in that the composition of this medicine is:
Realgar 18-22 gram Rhizoma Corydalis 22-26 gram Rhizoma Et Radix Notopterygii 18-22 gram
Catechu 18-22 gram Radix Dipsaci 18-22 gram Radix Bupleuri 18-22 gram
Radix Astragali 28-32 gram Semen Benincasae 28-32 gram Eriocheir sinensis 38-42 gram
Radix Angelicae Sinensis 18-22 gram Squama Manis 18-22 gram Radix Angelicae Pubescentis 18-22 gram
Eupolyphaga Seu Steleophaga 18-22 gram Radix Morindae Officinalis 18-22 gram Magnetitum 24-26 gram
Fructus Toosendan 24-26 gram Fructus Chaenomelis 18-22 gram Hirudo 14-16 gram
2,, it is characterized in that the composition of this medicine is according to the medicine of claim 1:
Realgar 20 gram Rhizoma Corydalis 25 gram Rhizoma Et Radix Notopterygiis 20 grams
Catechu 20 gram Radix Dipsaci 20 gram Radix Bupleuri 20 grams
The Radix Astragali 30 gram Semen Benincasaes 30 gram Eriocheir sinensiss 40 grams
Radix Angelicae Sinensis 20 gram Squama Maniss 20 gram Radix Angelicae Pubescentiss 20 grams
Eupolyphaga Seu Steleophaga 20 gram Radix Morindae Officinaliss 20 gram Magnetitums 25 grams
Fructus Toosendan 25 gram Fructus Chaenomeliss 20 gram Hirudos 15 grams
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN94114860A CN1043308C (en) | 1994-08-13 | 1994-08-13 | Drug for exterior use for treating necrosis of femoral head |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN94114860A CN1043308C (en) | 1994-08-13 | 1994-08-13 | Drug for exterior use for treating necrosis of femoral head |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1121818A CN1121818A (en) | 1996-05-08 |
CN1043308C true CN1043308C (en) | 1999-05-12 |
Family
ID=5037232
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN94114860A Expired - Fee Related CN1043308C (en) | 1994-08-13 | 1994-08-13 | Drug for exterior use for treating necrosis of femoral head |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1043308C (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1076617C (en) * | 1999-06-16 | 2001-12-26 | 王松彪 | Medicine specially for treating caput femoris necrosis, and method for preparing same |
CN1101219C (en) * | 1999-12-09 | 2003-02-12 | 张印昌 | Chinese-medicinal pills for treating ischemic necrosis of femur head |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1089164A (en) * | 1993-10-30 | 1994-07-13 | 王占礼 | The Chinese medicine preparation and the method for making thereof of treatment femoral head necrosis |
-
1994
- 1994-08-13 CN CN94114860A patent/CN1043308C/en not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1089164A (en) * | 1993-10-30 | 1994-07-13 | 王占礼 | The Chinese medicine preparation and the method for making thereof of treatment femoral head necrosis |
Also Published As
Publication number | Publication date |
---|---|
CN1121818A (en) | 1996-05-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1063945C (en) | External compress paste for discopathy | |
CN1895332A (en) | Oral and externally-applied Chinese medicinal preparation for treating osteoproliferation and its production | |
CN1054520C (en) | Drug for exterior use for treating necrosis of femoral head | |
CN1043308C (en) | Drug for exterior use for treating necrosis of femoral head | |
CN1049133C (en) | Oral medicine for treating necrosis of femoral head | |
CN1043307C (en) | Drug for exterior use for treating necrosis of femoral head | |
CN1634219A (en) | Orally administered Chinese medicinal powder and ointment for treating femoral head necroses and its preparation process | |
CN101496838A (en) | Chinese medicament preparation for treating hyperosteogeny and rheumatism and preparation method thereof | |
CN1284580C (en) | Bone Activating stasis transforming capsule | |
CN110840861B (en) | Cervical vertebra plaster for clearing and activating channels and collaterals, and preparation method and application thereof | |
CN1324650A (en) | Effective medicine for treating cervical vertebra disease as one kind of intractable disease | |
CN109432309B (en) | Traditional Chinese medicine composition, external medicinal liquor, and preparation method and application thereof | |
CN1443550A (en) | Chinese medicine for curing necrosis of femoral head | |
CN1076614C (en) | Exterior-applied powder medicine for treating lumbar intervertebral disk protrusion and preparing process | |
CN1250245C (en) | Capsule for treating osteonecrosis and bone fracture | |
CN108888736B (en) | External-use bone reunion medicine and preparation method thereof | |
CN108186756A (en) | A kind of bone healing plaster and preparation method thereof | |
CN1265817C (en) | Bone injury treating Chinese medicine capsule | |
CN1050289C (en) | Quick-acting antirheumatic | |
CN108815415B (en) | Externally-applied medicine for treating rheumatic ostealgia and preparation method thereof | |
CN1231237C (en) | Medicine for treating hyperosteogeny | |
CN110693967A (en) | Chinese medicinal preparation for treating aseptic necrosis of femoral head and preparation method thereof | |
CN1488388A (en) | Chinese medicine compositior for treating intervertebral disc osteoproliferation | |
CN1040507C (en) | Traditional Chinese medicinal board for compressed fracture of thoracic vertebra and lumber vertebra | |
CN1058171C (en) | Chinese drugs soft extract used to activate blood flow and its preparation method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C06 | Publication | ||
PB01 | Publication | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |